Bristol Myers Squibb RX
FDA Approved Drugs

Bristol Myers Squibb RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 23
  • Latest Approval Date Apr 17, 2025
  • Data Source FDA
  • First Approval Date Jun 20, 2003
All
217
View
Unclassified
12
View
Discontinued
182
View
RX
23
View
Company Overview

Company

Bristol Myers Squibb RX

Country

U.S.A

Website

Visit Website

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Bristol Myers Squibb RX

430 E. 29th Street, 14th Floor, New York, NY 10016

U.S.A

www.bms.com/ View on Map
FDA Approved Drug Records ( 23 records )
2005
29 Mar
RX Application: 21797

Drug Name

BARACLUDE

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2005-03-29

21797 / 1

Active Ingredient

ENTECAVIR

Application Number

21797

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2005-03-29

Regulatory Status

RX

2005
29 Mar
RX Application: 21797

Drug Name

BARACLUDE

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2005-03-29

21797 / 2

Active Ingredient

ENTECAVIR

Application Number

21797

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2005-03-29

Regulatory Status

RX

2005
29 Mar
RX Application: 21798

Drug Name

BARACLUDE

Product Number

1

Dosage Form

-

Strength

0.05MG/ML

Approval Date

2005-03-29

21798 / 1

Active Ingredient

ENTECAVIR

Application Number

21798

Product Number

1

Dosage Form

-

Strength

0.05MG/ML

Approval Date

2005-03-29

Regulatory Status

RX

2012
28 Dec
RX Application: 202155

Drug Name

ELIQUIS

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2012-12-28

202155 / 1

Active Ingredient

APIXABAN

Application Number

202155

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2012-12-28

Regulatory Status

RX

2012
28 Dec
RX Application: 202155

Drug Name

ELIQUIS

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2012-12-28

202155 / 2

Active Ingredient

APIXABAN

Application Number

202155

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2012-12-28

Regulatory Status

RX

2025
17 Apr
RX Application: 202155

Drug Name

ELIQUIS

Product Number

3

Dosage Form

-

Strength

0.5MG

Approval Date

2025-04-17

202155 / 3

Active Ingredient

APIXABAN

Application Number

202155

Product Number

3

Dosage Form

-

Strength

0.5MG

Approval Date

2025-04-17

Regulatory Status

RX

2017
01 Aug
RX Application: 209606

Drug Name

IDHIFA

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2017-08-01

209606 / 1

Active Ingredient

ENASIDENIB MESYLATE

Application Number

209606

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2017-08-01

Regulatory Status

RX

2017
01 Aug
RX Application: 209606

Drug Name

IDHIFA

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2017-08-01

209606 / 2

Active Ingredient

ENASIDENIB MESYLATE

Application Number

209606

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2017-08-01

Regulatory Status

RX

2005
27 Dec
RX Application: 21880

Drug Name

REVLIMID

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2005-12-27

21880 / 1

Active Ingredient

LENALIDOMIDE

Application Number

21880

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2005-12-27

Regulatory Status

RX

2005
27 Dec
RX Application: 21880

Drug Name

REVLIMID

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2005-12-27

21880 / 2

Active Ingredient

LENALIDOMIDE

Application Number

21880

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2005-12-27

Regulatory Status

RX

2006
29 Jun
RX Application: 21880

Drug Name

REVLIMID

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2006-06-29

21880 / 3

Active Ingredient

LENALIDOMIDE

Application Number

21880

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2006-06-29

Regulatory Status

RX

2006
29 Jun
RX Application: 21880

Drug Name

REVLIMID

Product Number

4

Dosage Form

-

Strength

25MG

Approval Date

2006-06-29

21880 / 4

Active Ingredient

LENALIDOMIDE

Application Number

21880

Product Number

4

Dosage Form

-

Strength

25MG

Approval Date

2006-06-29

Regulatory Status

RX

2011
21 Dec
RX Application: 21880

Drug Name

REVLIMID

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

2011-12-21

21880 / 5

Active Ingredient

LENALIDOMIDE

Application Number

21880

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

2011-12-21

Regulatory Status

RX

2013
05 Jun
RX Application: 21880

Drug Name

REVLIMID

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2013-06-05

21880 / 6

Active Ingredient

LENALIDOMIDE

Application Number

21880

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2013-06-05

Regulatory Status

RX

2003
20 Jun
RX Application: 21567

Drug Name

REYATAZ

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2003-06-20

21567 / 3

Active Ingredient

ATAZANAVIR SULFATE

Application Number

21567

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2003-06-20

Regulatory Status

RX

2006
16 Oct
RX Application: 21567

Drug Name

REYATAZ

Product Number

4

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2006-10-16

21567 / 4

Active Ingredient

ATAZANAVIR SULFATE

Application Number

21567

Product Number

4

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2006-10-16

Regulatory Status

RX

2014
02 Jun
RX Application: 206352

Drug Name

REYATAZ

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/PACKET

Approval Date

2014-06-02

206352 / 1

Active Ingredient

ATAZANAVIR SULFATE

Application Number

206352

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/PACKET

Approval Date

2014-06-02

Regulatory Status

RX

2006
28 Jun
RX Application: 21986

Drug Name

SPRYCEL

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2006-06-28

21986 / 1

Active Ingredient

DASATINIB

Application Number

21986

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2006-06-28

Regulatory Status

RX

2006
28 Jun
RX Application: 21986

Drug Name

SPRYCEL

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2006-06-28

21986 / 2

Active Ingredient

DASATINIB

Application Number

21986

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2006-06-28

Regulatory Status

RX

2006
28 Jun
RX Application: 21986

Drug Name

SPRYCEL

Product Number

3

Dosage Form

-

Strength

70MG

Approval Date

2006-06-28

21986 / 3

Active Ingredient

DASATINIB

Application Number

21986

Product Number

3

Dosage Form

-

Strength

70MG

Approval Date

2006-06-28

Regulatory Status

RX

2008
30 May
RX Application: 21986

Drug Name

SPRYCEL

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2008-05-30

21986 / 4

Active Ingredient

DASATINIB

Application Number

21986

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2008-05-30

Regulatory Status

RX

2010
28 Oct
RX Application: 21986

Drug Name

SPRYCEL

Product Number

5

Dosage Form

-

Strength

80MG

Approval Date

2010-10-28

21986 / 5

Active Ingredient

DASATINIB

Application Number

21986

Product Number

5

Dosage Form

-

Strength

80MG

Approval Date

2010-10-28

Regulatory Status

RX

2010
28 Oct
RX Application: 21986

Drug Name

SPRYCEL

Product Number

6

Dosage Form

-

Strength

140MG

Approval Date

2010-10-28

21986 / 6

Active Ingredient

DASATINIB

Application Number

21986

Product Number

6

Dosage Form

-

Strength

140MG

Approval Date

2010-10-28

Regulatory Status

RX

Related Databases
  • FDA Inspections
    9 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    217 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
23 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BARACLUDE

Application Number

21797

Product Number

1

Active Ingredient

ENTECAVIR

Dosage Form

-

Strength

0.5MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit